e.g. mhealth
Search Results (1 to 10 of 15 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 6 JMIR Research Protocols
- 2 JMIR mHealth and uHealth
- 1 Interactive Journal of Medical Research
- 1 JMIR AI
- 1 JMIR Cardio
- 1 JMIR Human Factors
- 1 JMIR Medical Informatics
- 1 JMIR Public Health and Surveillance
- 1 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 iProceedings
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Formative Research
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Despite a mean CPAP compliance of 2.5 hours nightly, and an overall compliance (≥ 4 hours nightly) of 32.7% of participants randomized to CPAP, this reported reductions in diastolic blood pressure and preeclampsia rates [23].
JMIR Res Protoc 2025;14:e51434
Download Citation: END BibTex RIS
Informatics Interventions for Maternal Morbidity: Scoping Review
Maternal morbidities such as preeclampsia and gestational diabetes, and severe maternal morbidities such as postpartum hemorrhage all have implications for the long-term health of mothers well beyond the postpartum period. Preeclampsia is associated with cardiovascular disease for decades following pregnancy, including chronic hypertension, stroke, and age-adjusted overall mortality [2].
Interact J Med Res 2025;14:e64826
Download Citation: END BibTex RIS
Predictive Modeling of Hypertension-Related Postpartum Readmission: Retrospective Cohort Analysis
Similarly, we hypothesized that antihypertensive medication administration and high preeclampsia laboratory values during initial readmission would increase the readmission rate.
We obtained institutional review board approval (#2016-006). Individual patient consent was not required due to the retrospective study design. The data set was deidentified before study analysis.
JMIR AI 2024;3:e48588
Download Citation: END BibTex RIS
Preeclampsia diagnosed before 34 weeks of gestation is called early-onset preeclampsia, and late-onset preeclampsia is diagnosed after 34 weeks [4]. To allow for maximal efficiency of prevention therapy, tools that accurately predict the onset time of preeclampsia and the patient risk will be extremely beneficial.
J Med Internet Res 2024;26:e48997
Download Citation: END BibTex RIS
Preeclampsia (PE) is one of the most common hypertensive diseases in pregnancy, characterized by elevated blood pressure accompanied by proteinuria or organ damage after 20 weeks of gestation [1]. The incidence of PE is approximately 2%-8% worldwide [2,3], and each year, an estimated 76,000 women and 500,000 fetuses die from PE and related complications [4]. Symptoms of PE are not specific, including headache, visual impairment, upper abdominal pain, and shortness of breath, among others.
JMIR Res Protoc 2024;13:e54026
Download Citation: END BibTex RIS
Variables, however, were similarly defined across patients (eg, race, ethnicity, and preeclampsia). The EHR data were deidentified before analyses, enabling HOPE-CAT to truly analyze the data without consideration of race, ethnicity, or other variables that may lead to bias. Race, ethnicity, medical history, and family history were self-reported by patients and defined as recorded in the EHR.
JMIR Cardio 2024;8:e53091
Download Citation: END BibTex RIS
However, it is unknown whether the increased ASD risk associated with preeclampsia is due to preeclampsia onset or clinical management of preeclampsia after the onset. Identifying the risk associated with preeclampsia onset and exposure is important to provide evidence supporting the care of high-risk pregnancies and to reduce adverse effects on offspring.
JMIR Public Health Surveill 2024;10:e47396
Download Citation: END BibTex RIS
The spectrum of HDP includes gestational hypertension (GH); preeclampsia; eclampsia; and hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. Preeclampsia is a complication of 2%-8% of all pregnancies worldwide, contributing to 16%, 9%, and 1.6%-2.5% maternal deaths globally, in Asia and Africa, and in Malaysia, respectively [4,5]. HDP is one of several disorders associated with vitamin D deficiency [6].
JMIR Res Protoc 2024;13:e53722
Download Citation: END BibTex RIS
According to American College of Obstetricians and Gynecologists guidelines, hypertension in pregnancy is classified as chronic or preexisting hypertension, gestational hypertension, preeclampsia or eclampsia, chronic or preexisting hypertension with superimposed preeclampsia-eclampsia, mild hypertension, and severe hypertension [2].
JMIR Res Protoc 2023;12:e51792
Download Citation: END BibTex RIS
Placental dysfunction is a major cause of intrauterine growth restriction (IUGR) or preeclampsia (PE) and is responsible for maternofetal mortality and morbidity such as fetal death, preterm delivery, minor cognitive deficits, school problems, and metabolic syndrome in adulthood [1-3]. Normal placental development is an essential prerequisite for efficient placental function followed by fetal growth.
JMIR Res Protoc 2022;11(8):e35051
Download Citation: END BibTex RIS